“We want to invest the money and play catch up with our retirement savings/funding.”
Looking through to 2027, UBS upgrades ‘quality compounder’ ASML to buy
UBS analysts recommend investors focus on the 20% eps CAGR ASML is expected to deliver between 2027 and 2030
